Professor | Dandan Lin | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Dandan Lin
Contact Information	236772452@qq.com
Language ability	Chinese, English
Province	Hubei

Upload Avatar (500 x 500)

Name

Dandan Lin

Contact Information

236772452@qq.com

Language ability

Chinese, English

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	2004-2012: PhD in Clinical Medicine from Wuhan University Studied at top institutions in the USA and China Published high-impact SCI papers
Work Experience	2012.07-2016.12: Attending Physician, Oncology Department III, Renmin Hospital, Wuhan University 2016.12-2020.07: Associate Chief Physician, Oncology Department III, Renmin Hospital, Wuhan University 2017.07-2018.06: Visiting Scholar, Radiation Oncology, UT Southwestern Medical Center, USA 2019.07-2022.05: Associate Chief Physician, Associate Professor, Master's Supervisor, Oncology Department III, Renmin Hospital, Wuhan University 2022.06-present: Deputy Director, Chief Physician, Associate Professor, Master's Supervisor, Oncology Department III, Renmin Hospital, Wuhan University
Awards	First Hubei Province Outstanding Young Talent 2021 Wuhan City Young and Middle-aged Medical Backbone Talent 2019 Wuhan University Young Top Talent 2017 Key Talent of Renmin Hospital of Wuhan University 2017

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

2004-2012: PhD in Clinical Medicine from Wuhan University
Studied at top institutions in the USA and China
Published high-impact SCI papers

Work Experience

2012.07-2016.12: Attending Physician, Oncology Department III, Renmin Hospital, Wuhan University
2016.12-2020.07: Associate Chief Physician, Oncology Department III, Renmin Hospital, Wuhan University
2017.07-2018.06: Visiting Scholar, Radiation Oncology, UT Southwestern Medical Center, USA
2019.07-2022.05: Associate Chief Physician, Associate Professor, Master's Supervisor, Oncology Department III, Renmin Hospital, Wuhan University
2022.06-present: Deputy Director, Chief Physician, Associate Professor, Master's Supervisor, Oncology Department III, Renmin Hospital, Wuhan University

Awards

First Hubei Province Outstanding Young Talent 2021
Wuhan City Young and Middle-aged Medical Backbone Talent 2019
Wuhan University Young Top Talent 2017
Key Talent of Renmin Hospital of Wuhan University 2017

Areas of Focus	Tumor immunology and immunotherapy Gastrointestinal and lung cancer targeted intervention and molecular regulation
Publications	The E3 ubiquitin ligase ARIH1 promotes antiviral immunity and autoimmunity by inducing mono-ISGylation and oligomerization of cGAS, Xiong TC, Wei MC, Li FX, Shi M, Gan H, Tang Z, Dong HP, Liuyu T, Gao P, Zhong B, Zhang ZD, Lin D, 2022 IL-36g and IL-36Ra reciprocally regulate NSCLC progression by modulating GSH homeostasis and oxidative stress-induced cell death, Wang P, Yang W, Guo H, Dong HP, Guo YY, Gan H, Wang Z, Cheng Y, Deng Y, Xie S, Yang X, Lin D, Zhong B, 2021 CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer, Zhang M, Yang W, Wang P, Deng Y, Dong YT, Liu FF, Huang R, Zhang P, Duan YQ, Liu XD, Lin D, Chu Q, Zhong B, 2020 Induction of USP25 by viral infection promotes innate antiviral responses by mediating the stabilization of TRAF3 and TRAF6, Lin D, Zhang M, Zhang MX, Ren YJ, Zhao Q, Jin J, Pan Z, Wu M, Shu HB, Dong C, Zhong B, 2015 USP49 negatively regulates cellular antiviral responses via deconjugating K63-linked ubiquitination of MITA, Ye L, Zhang Q, Liuyu T, Xu Z, Zhang MX, Luo MH, Zeng WB, Zhu Q, Lin D, Zhong B, 2019 USP20 promotes cellular antiviral responses via deconjugating K48-linked ubiquitination of MITA, Zhang MX, Cai Z, Zhang M, Wang XM, Wang Y, Zhao F, Zhou J, Luo MH, Zhu Q, Xu Z, Zeng WB, Zhong B, Lin D, 2019 Regulation of T helper cell differentiation by E3 ubiquitin ligases and deubiquitinating enzymes, Gao SF, Zhong B, Lin D, 2017

Areas of Focus

Tumor immunology and immunotherapy
Gastrointestinal and lung cancer targeted intervention and molecular regulation

Publications

The E3 ubiquitin ligase ARIH1 promotes antiviral immunity and autoimmunity by inducing mono-ISGylation and oligomerization of cGAS, Xiong TC, Wei MC, Li FX, Shi M, Gan H, Tang Z, Dong HP, Liuyu T, Gao P, Zhong B, Zhang ZD, Lin D, 2022
IL-36g and IL-36Ra reciprocally regulate NSCLC progression by modulating GSH homeostasis and oxidative stress-induced cell death, Wang P, Yang W, Guo H, Dong HP, Guo YY, Gan H, Wang Z, Cheng Y, Deng Y, Xie S, Yang X, Lin D, Zhong B, 2021
CCL7 recruits cDC1 to promote antitumor immunity and facilitate checkpoint immunotherapy to non-small cell lung cancer, Zhang M, Yang W, Wang P, Deng Y, Dong YT, Liu FF, Huang R, Zhang P, Duan YQ, Liu XD, Lin D, Chu Q, Zhong B, 2020
Induction of USP25 by viral infection promotes innate antiviral responses by mediating the stabilization of TRAF3 and TRAF6, Lin D, Zhang M, Zhang MX, Ren YJ, Zhao Q, Jin J, Pan Z, Wu M, Shu HB, Dong C, Zhong B, 2015
USP49 negatively regulates cellular antiviral responses via deconjugating K63-linked ubiquitination of MITA, Ye L, Zhang Q, Liuyu T, Xu Z, Zhang MX, Luo MH, Zeng WB, Zhu Q, Lin D, Zhong B, 2019
USP20 promotes cellular antiviral responses via deconjugating K48-linked ubiquitination of MITA, Zhang MX, Cai Z, Zhang M, Wang XM, Wang Y, Zhao F, Zhou J, Luo MH, Zhu Q, Xu Z, Zeng WB, Zhong B, Lin D, 2019
Regulation of T helper cell differentiation by E3 ubiquitin ligases and deubiquitinating enzymes, Gao SF, Zhong B, Lin D, 2017

Immunology Immunotherapy Tumor Cancer Gastrointestinal Lung Targeted Therapy Molecular Biology Regulation Intervention

Jin Tang Dong - Southern University of Science and Technology

Yuliang Feng - Southern University of Science and Technology

Quan Liu - Southern University of Science and Technology

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us